3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Vomiting
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Nausea and Vomiting
1
Philadelphia Chromosome
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Nausea
1
Metastatic Neuroendocrine Prostate Cancer
1
Medulloblastoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Neoplasms
1
Ependymoma
1
Colorectal Neoplasms
1
Chondrosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Bulbo-Spinal Atrophy, X-Linked
1
Advanced Solid Tumors
1
Interventions
Dexamethasone
5
ramosetron
3
Ondansetron
2
Calcium Dobesilate
2
Acupuncture Therapy
2
phenazine
1
esmolol
1
Therapeutics
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Olanzapine
1
Gelatin
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Aprepitant
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Adrenergic beta-Antagonists
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Postoperative Nausea and Vomiting
×
Antiemetics
×
Clear all
NCT02509143
2024-08-12
AcuPONV
Pusan National University Yangsan Hospital
Phase NA
Completed
60 enrolled